Raven-Symoné, Breast Reduction

Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...
Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...
While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...
The company found that the 1 mg dose of Z-endoxifen reduced MBD by 17.3 percentage points, whereas the 2 mg dose achieved a reduction of 23.5 percentage points. Meanwhile, a minimal change of 0.27 ...
Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...